Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
66
DXCM Quote, Financials, Valuation and Earnings
Last price:
$80.09
Seasonality move
:
6.97%
Day range:
$75.47 - $81.51
52-week range:
$62.34 - $142.00
Dividend yield:
0%
P/E ratio:
47.93x
P/S ratio:
8.40x
P/B ratio:
15.80x
Volume:
11.5M
Avg. volume:
3.9M
1-year change:
-31.38%
Market cap:
$31.3B
Revenue:
$3.6B
EPS (TTM):
$1.67
DexCom SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
DXCM
DexCom
|
04/25/2024 | 10-Q | 10-Q filing on 04/25/2024 | View Form |
|
DXCM
DexCom
|
10/26/2023 | 10-Q | 10-Q filing on 10/26/2023 | View Form |
|
DXCM
DexCom
|
07/27/2023 | 10-Q | 10-Q filing on 07/27/2023 | View Form |
|
DXCM
DexCom
|
04/27/2023 | 10-Q | 10-Q filing on 04/27/2023 | View Form |
|
DXCM
DexCom
|
10/27/2022 | 10-Q | 10-Q filing on 10/27/2022 | View Form |
|
DXCM
DexCom
|
07/28/2022 | 10-Q | 10-Q filing on 07/28/2022 | View Form |
|
DXCM
DexCom
|
04/28/2022 | 10-Q | 10-Q filing on 04/28/2022 | View Form |
|
DXCM
DexCom
|
10/28/2021 | 10-Q | 10-Q filing on 10/28/2021 | View Form |
|
DXCM
DexCom
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
DXCM
DexCom
|
04/29/2021 | 10-Q | 10-Q filing on 04/29/2021 | View Form |
|
DXCM
DexCom
|
02/11/2021 | 10-K | 10-K filing on 02/11/2021 | View Form |
|
DXCM
DexCom
|
10/27/2020 | 10-Q | 10-Q filing on 10/27/2020 | View Form |
|
DXCM
DexCom
|
07/28/2020 | 10-Q | 10-Q filing on 07/28/2020 | View Form |
|
DXCM
DexCom
|
04/28/2020 | 10-Q | 10-Q filing on 04/28/2020 | View Form |
|
DXCM
DexCom
|
02/13/2020 | 10-K | 10-K filing on 02/13/2020 | View Form |
|
DXCM
DexCom
|
11/06/2019 | 10-Q | 10-Q filing on 11/06/2019 | View Form |
|
DXCM
DexCom
|
07/31/2019 | 10-Q | 10-Q filing on 07/31/2019 | View Form |
|
DXCM
DexCom
|
05/01/2019 | 10-Q | 10-Q filing on 05/01/2019 | View Form |
|
DXCM
DexCom
|
02/21/2019 | 10-K | 10-K filing on 02/21/2019 | View Form |
|
DXCM
DexCom
|
11/06/2018 | 10-Q | 10-Q filing on 11/06/2018 | View Form |
|
DXCM
DexCom
|
08/01/2018 | 10-Q | 10-Q filing on 08/01/2018 | View Form |
|
DXCM
DexCom
|
05/02/2018 | 10-Q | 10-Q filing on 05/02/2018 | View Form |
|
DXCM
DexCom
|
02/27/2018 | 10-K | 10-K filing on 02/27/2018 | View Form |
|
DXCM
DexCom
|
11/01/2017 | 10-Q | 10-Q filing on 11/01/2017 | View Form |
|
DXCM
DexCom
|
08/01/2017 | 10-Q | 10-Q filing on 08/01/2017 | View Form |
|
DXCM
DexCom
|
05/02/2017 | 10-Q | 10-Q filing on 05/02/2017 | View Form |
|
DXCM
DexCom
|
02/28/2017 | 10-K | 10-K filing on 02/28/2017 | View Form |
|
DXCM
DexCom
|
11/01/2016 | 10-Q | 10-Q filing on 11/01/2016 | View Form |
|
DXCM
DexCom
|
08/02/2016 | 10-Q | 10-Q filing on 08/02/2016 | View Form |
|
DXCM
DexCom
|
04/27/2016 | 10-Q | 10-Q filing on 04/27/2016 | View Form |
|
DXCM
DexCom
|
02/23/2016 | 10-K | 10-K filing on 02/23/2016 | View Form |
|
DXCM
DexCom
|
11/04/2015 | 10-Q | 10-Q filing on 11/04/2015 | View Form |
|
DXCM
DexCom
|
08/05/2015 | 10-Q | 10-Q filing on 08/05/2015 | View Form |
|
DXCM
DexCom
|
04/29/2015 | 10-Q | 10-Q filing on 04/29/2015 | View Form |
|
DXCM
DexCom
|
02/25/2015 | 10-K | 10-K filing on 02/25/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
